DariusJohnAdamsMD
Medical Genetics • Morristown, NJClinical Biochemical Genetics, Clinical Genetics
Director, Personalized Genomic Medicine
Dr. Adams is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
101 Madison Avenue
Suite 107
Morristown, NJ 07960
Education & Training
Icahn School of Medicine at Mount SinaiResidency, Medical Genetics and Genomics, 1997 - 2001
Rutgers New Jersey Medical SchoolClass of 1997
Certifications & Licensure
NJ State Medical License 2013 - 2025
NY State Medical License 1999 - 2025- American Board of Medical Genetics and Genomics Clinical Biochemical Genetics
- American Board of Medical Genetics and Genomics Clinical Genetics and Genomics
Awards, Honors, & Recognition
- Inside Jersey Magazine Top Doctors Castle Connolly, 2014
- Hudson Valley Magazine Castle Connolly, 2013
Clinical Trials
- An Open-Label Phase 3 Study of BMN 165 for Adults With PKU Not Previously Treated w/ BMN 165 Start of enrollment: 2013 May 01
- AAV Gene Therapy Study for Subjects With PKU Start of enrollment: 2020 Sep 24
Publications & Presentations
PubMed
- 139 citationsNewborn screening for Krabbe disease: the New York State model.Patricia K. Duffner, Michele Caggana, Joseph J. Orsini, David A. Wenger, Marc C. Patterson
Pediatric Neurology. 2009-04-01 - 71 citationsNewborn screening for Krabbe disease in New York State: the first eight years' experience.Joseph J. Orsini, Denise M. Kay, Carlos A. Saavedra-Matiz, David A. Wenger, Patricia K. Duffner
Genetics in Medicine. 2016-03-01 - 21 citationsPhenotype delineation of ZNF462 related syndromePaul Kruszka, Tommy Hu, Sung-Kook Hong, Rebecca Signer, Benjamin Cogné
American Journal of Medical Genetics. Part A. 2019-10-01
Press Mentions
CTD Announces Home-Based Dosing of First Patient in US Extension Protocol of Clinical Trial Using Intravenous Administration of Trappsol (R) Cyclo (TM) for Niemann-Pick Disease Type CMay 23rd, 2019
CTD Holdings to Host Webinar on Its Phase I Clinical Trial for Niemann-Pick Disease Type COctober 11th, 2018- CTD Announces New Expanded Access Program in Taiwan Using Trappsol Cyclo for Niemann-Pick Disease Type CMay 8th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
